Clinical Trials Directory

Trials / Unknown

UnknownNCT00969800

Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections

Double-blind Sham Device-controlled Multi-center Crossover Trial of Chlorine Dioxide Gas on the Protective Effect Against Respiratory Infections

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,469 (actual)
Sponsor
Taiko Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

This study is to test whether a chlorine dioxide gas-generating device, which releases a low concentration gas of chlorine dioxide in a sustained manner, can protect against respiratory infections in elderly individuals living in nursing homes. Such a device is used as a deodorant for normal domestic purposes. The investigators reasoned that the antiviral and antibacterial properties of chlorine dioxide might lead to a lowering in the incidence of respiratory infectious diseases. The study is designed as a randomized placebo-controlled double-blind crossover multicentre trial involving approximately 1500 subjects.

Detailed description

Chlorine dioxide (ClO2), which is used as household deodorant, is a volatile gas that displays very strong oxidative activity. Indeed, the powerful oxidative activity of chlorine dioxide (Ogata, N., Biochemistry 46, 4898-4911, 2007) is responsible for its antimicrobial activity against bacteria (Benarde, M. A., et al. Appl. Mircrobiol. 15, 257-265, 1967), fungi (Morino, H., et al. Yakugaku Zasshi 127, 773-777, 2007) and viruses (Ogata, N. and Shibata, T. J. Gen. Virol. 89, 60-67, 2008). Recently, we found that the rate of absenteeism due to illness in a school was lower in classrooms where a chlorine dioxide gas-generating device was placed than in classrooms with no such device. Based upon this unexpected observation we hypothesize that chlorine dioxide gas, at a concentration low enough not to harm humans, may lower the incidence of respiratory infections by inactivating airborne microorganism within an enclosed space.

Conditions

Interventions

TypeNameDescription
DEVICECleverin GelChlorine dioxide gas concentration at a range of 0.005 to 0.03 ppm.
DEVICEInactive Cleverin GelSeemingly same chlorine dioxide gas-generating device, but no gas is generated.

Timeline

Start date
2009-10-01
Primary completion
2010-03-01
Completion
2010-04-01
First posted
2009-09-01
Last updated
2010-02-04

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00969800. Inclusion in this directory is not an endorsement.